Singapore
Econ Healthcare to book $3.4m loss in Crosstec exit
The loss will not have any material impact on the company.
Econ Healthcare to book $3.4m loss in Crosstec exit
The loss will not have any material impact on the company.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
Hilleman Laboratories invests $80m in vaccine development hub
The new facility is the first of its kind in Singapore.
NSG BioLabs doubles capacity with new site
The expansion aims to facilitate the growth of promising biotech companies.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
SMART AMR develops first-of-its-kind 10-minute COVID immunity test
The new point-of-care test offers an accuracy rate of up to 93%.
Labcorp adds 90 additional research and engineering jobs
This came as the life sciences company opened its new bioanalytical laboratory.
SingHealth and SGInnovate partner to ramp up health science innovations
Artificial intelligence in healthcare will be the first area of focus.
Singapore-developed dementia screening tool goes global
The VCAT addresses the challenges of dementia screening in multi-lingual countries.
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.
SG can ramp up ICU capacity but lacks people: Puthucheary
The minister addressed the Parliament about intensive care units and hospital capacity.
SingHealth Duke-NUS invests in 'the seeds of the future generation'
It launched a new institute that opens doors for maternal-child care research.
MCHRI enters partnership with Menarini Biomarkers
The two will create a regional and international hub for non-invasive diagnostics in Singapore.
SingHealth Duke-NUS opens MCHRI
The institute aims to serve as a maternal and child health research centre.
Greater Houston Healthconnect Uses InterSystems HealthShare® to Create Largest Known COVID-19 Outcomes Study
GHH has assembled a cohort of more than one million COVID-19 positive cases with all associated medical histories for outcomes analysis.
'Sandwich generation' most impacted by COVID-19 crisis: Prudential
They are the 35- to 54-year-old adults caring for both parents and children.
Farrer Park Hospital enhances dementia services with AI MRI screening
This aims to provide more comprehensive results.